Burkitt-Tumor

  • Johann Rastetter
Part of the Handbuch Der Inneren Medizin book series (INNEREN, volume 2 / 5)

Zusammenfassung

Zentralafrikanisches Lymphom, Burkitt-Lymphom, malignes Lymphom, epidemisches Lymphosarkom.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ablin, A., B. G. Stephens, T. Hirata, K. Wilson, and H. E. Williams: Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt’s lymphoma treated with chemotherapy and allopurinol. Metabolism 21, 771 (1972).PubMedCrossRefGoogle Scholar
  2. Achong, B. G., and M. A. Epstein: Fine structure of the Burkitt tumour. J. nat. Cancer Inst. 36, 877 (1966).Google Scholar
  3. Ambras, J. L., and H. V. Strandström: Complement fixing antibodies against cultured neoplastic cells in sera from normal individuals. Proc. Amer. Ass. Cancer Res. 8, 2 (1967).Google Scholar
  4. Armstrong, D., G. Henle, and W. Henle: Complement fixation tests with cell lines derived from Burkitt’s lymphoma and acute leukemia. J. Bact. 91, 1257 (1966).PubMedGoogle Scholar
  5. Arseneau, J. C, C. M. Bagley, T. Anderson, and G. P. Canellos: Hyperkalemia, a sequel to chemotherapy of Burkitt’s lymphoma. Lancet 1973 I, 10.CrossRefGoogle Scholar
  6. Atkinson, L.: A cancer registry in Australia, New Guinea. E. Afr. med. J. 42, 249 (1965).Google Scholar
  7. Bell, T. M.: Review of the evidence for a viral aetiology for Burkitt’s lymphome. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  8. Bell, T. M.: Isolation of reovirus type 3. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  9. Bell, T. M., and M. G. R. Ross: Persistent latent infection of human embryonic cells with reovirus type 3. Nature (Lond.) 212, 412 (1966).CrossRefGoogle Scholar
  10. Bell, T. M., and M. C. Williams: Isolation of a reovirus from a case of Burkitt’s lymphoma. Brit. med. J. 1964 I, 1212.Google Scholar
  11. Bell, T. M., A. Massie, M. G. R. Ross, D. I. H. Simpson, and E. Griffin: Further isolations of reovirus type 3 from cases of Burkitt’s lymphoma. Brit. med. J. 1966 I, 1514.CrossRefGoogle Scholar
  12. Beltrán, G., A. Baez, and P. Correa: Burkitt’s lymphoma in Colombia. Amer. J. med. 40, 211 (1966).PubMedCrossRefGoogle Scholar
  13. Bennet, E.: Zitiert nach Burkitt, D. P. In: Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  14. Benyesch-Melnick, M., D. J. Fernbach, S. I. Dessy, and R. T. Lewis: Studies on acute leukemia and infections mononucleosis of childhood. III. Incidence of spontaneous lymphoblastoid transformation in bone marrow cultures. J. nat. Cancer Inst. 40, 111 (1968).Google Scholar
  15. Bernhard, W.: Fine structure of Burkitt’s lymphoma. In: Burkitt, D. P,. and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  16. Bernhard, W., et D. Lambert: Ultrastructure des tumeurs de Burkitt de l’enfance africain. In: Roulet, F. C. (Ed.): The lymphoreticular tumours in Africa. Basel and New York: S. Karger 1964.Google Scholar
  17. Berry, C. G.: Lymphoma syndrome in Northern Nigeria. Brit. med. J. 1964 II, 668.CrossRefGoogle Scholar
  18. Bishun, N. P., and R. N. P. Sutton: Cytogenetic and other studies on the EB 4 line of Burkitt tumour cells. Brit. J. Cancer 21, 675 (1968).CrossRefGoogle Scholar
  19. Bluming, A. Z., and A. A. Serpick: Treatment of recurrent Burkitt’s tumor with autologous remission plasma. Oncology 24, 304 (1970).PubMedCrossRefGoogle Scholar
  20. Bluming, A. Z., and A. C. Templeton: Histological diagnosis of Burkitt’s lymphoma: A cautionary tale. Brit. med. J. 1971 1, 89.PubMedCrossRefGoogle Scholar
  21. Bluming, A. Z., J. L. Ziegler, and P. P. Carbone: Bone marrow involvement in Burkitt’s lymphoma: Results of a prospective study. Brit. J. haemat. 22, 369 (1972).PubMedCrossRefGoogle Scholar
  22. Bluming, A. Z., J. L. Ziegler, L. Fass, and R. B. Herberman: Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study. Clin. exp. Immunol. 9, 713 (1971).PubMedGoogle Scholar
  23. Booth, K., D. Burkitt, D. J. Bassett, R. A. Cooke, and J. Biddulph: Burkitt lymphoma in Papua, New Guinea. Brit. J. Cancer 21, 657 (1967).PubMedCrossRefGoogle Scholar
  24. Braband, H.: Burkitt-Tumor. Stuttgart: Thieme 1968.Google Scholar
  25. Burchenal, J. H.: Formal discussion: long term survival in Burkitt’s tumor and in acute leukemia. Cancer Res. 27, 2616 (1967).PubMedGoogle Scholar
  26. Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  27. Burkitt, D. P.: A sarcoma involving the jaws in African children. Brit. J. Surg. 46, 216 (1958).CrossRefGoogle Scholar
  28. Burkitt, D. P.: Determining the climatic limitations of a children’s cancer common in Africa. Brit. med. J. 1962 II, 1019.CrossRefGoogle Scholar
  29. Burkitt, D. P.: A tumour safari in East and Central Africa. Brit. J. Cancer 16, 379 (1962).PubMedCrossRefGoogle Scholar
  30. Burkitt, D. P.: A children’s cancer dependent on climatic factors. Nature (Lond.) 194, 232 (1962).CrossRefGoogle Scholar
  31. Burkitt, D. P.: African lymphoma. Observations on response to vincristine sulphate therapy. Cancer (Philad.) 19, 1131 (1966).CrossRefGoogle Scholar
  32. Burkitt, D. P.: Long term remissions following one and two-dose chemotherapy for African lymphoma Cancer (Philad.) 20, 756 (1967).CrossRefGoogle Scholar
  33. Burkitt, D. P.: Chemotherapy of African (Burkitt) lymphoma. Clinical evidence suggesting an immunological response. Brit. J. Surg. 54, 817 (1967).CrossRefGoogle Scholar
  34. Burkitt, D. P.: Chemotherapy of jaw tumours. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  35. Burkitt, D. P.: Recent developments in geographical distribution. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  36. Burkitt, D. P.: Some clinical features. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  37. Burkitt, D. P.: Der Burkitt-Tumor in klinischer und epidemiologischer Sicht. Med. Klin. 63, 653 (1968).Google Scholar
  38. Burkitt, D. P.: Etiology of Burkitt’s lymphoma an alternative hypothesis to a vectored virus. J. nat. Cancer Inst. 42, 19 (1969).PubMedGoogle Scholar
  39. Burkitt, D. P.: General features and facial tumours. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  40. Burkitt, D. P.: Lesions outside the jaw. In: Burkitt D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  41. Burkitt, D. P.: Treatment, general features. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  42. Burkitt, D. P., M. S. R. Hutt, and D. H. Wright: The African lymphoma. Preliminary observations on response to therapy. Cancer (Philad.) 18, 399 (1965).CrossRefGoogle Scholar
  43. Burkitt, D. P., and S. K. Kyalwazi: Spontaneous remission of African lymphoma. Brit. J. Cancer 21, 14 (1967).PubMedCrossRefGoogle Scholar
  44. Burkitt, D. P., and G. T. O’Conor: Malignant lymphoma in African children: I. Clinical syndrome. Cancer (Philad.) 14, 258 (1961).CrossRefGoogle Scholar
  45. Burkitt, D. P., A. M. M. Wilson, and D. B. Jelliffe: Subcutaneous phycomycosis: a review of 31 cases seen in Uganda. Brit. med. J. 1964 I, 1669.CrossRefGoogle Scholar
  46. Burkitt, D. P., and D. H. Wright: Geographical and tribal distribution of the African lymphoma in Uganda. Brit. med. J. 1966 I, 569.Google Scholar
  47. Caniain, R., et D. Lambert: Les hématosarcomes de la face chez l’enfant en Afrique. (Maladie de Burkitt). Rev. franç. Étud. clin. biol. 10, 587 (1968).Google Scholar
  48. Carbone, P. P.: Non-Hodgkin’s lymphoma: Recent observations on natural history and intensive treatment. Cancer (Philad.) 30, 1511 (1972).CrossRefGoogle Scholar
  49. Chapman, D. S., and T. Jenkins: The Burkitt lymphoma in Natal: A significant medical tail. Med. Proc. 9, 320 (1963).Google Scholar
  50. Chessin, L. N., P. R. Glade, J. A. Kasel, H. L. Moses, R. B. Heberman, and Y. Hirshaut: The circulating lymphocyte—its role in infectious mononucleosis. Ann. intern. Med. 69, 333 (1968).PubMedGoogle Scholar
  51. Chu, E. W., J. J. K. Whang, and A. S. Rabson: Cytogenetic studies of lymphoma cells from an American patient with a tumor similar to Burkitt’s tumors in African children. J. nat. Cancer Inst. 37, 885 (1966).PubMedGoogle Scholar
  52. Clifford, P.: Malignant disease of the nose, paranasal sinuses and post-nasal space in East Africa. J. Laryng. 75, 707 (1961).PubMedCrossRefGoogle Scholar
  53. Clifford, P.: Further studies in the treatment of Burkitt’s lymphoma. E. Afr. med. J. 43, 179 (1966).Google Scholar
  54. Clifford, P.: Observations on the treatment of Burkitt’s lymphoma. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  55. Clifford, P.: Treatment, response to particular chemotherapeutic and other agents and treatment of CNS involvement. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  56. Clifford, P., S. Singh, J. Stjernswärd, and G. Klein: Long term survival of patients with Burkitt’s lymphoma: an assessment of treatment and other factors which may relate to survival. Cancer Res. 27, 2578 (1967).PubMedGoogle Scholar
  57. Clift, R. A., D. H. Wright, and P. Clifford: Leukemia in Burkitt’s lymphoma. Blood 22, 243 (1963).PubMedGoogle Scholar
  58. Cockshot, W. P.: Radiology of Burkitt’s tumour in young Nigerians. In: Roulet, F. C. (Ed.): Symposium on lymphoreticular tumours in Africa. Basel: Karger 1964.Google Scholar
  59. Cockshott, W. P.: Radiological features. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  60. Cockshot, W. P., and K. T. Evans: Childhood paraplegia in lymphosarcoma (Burkitt’s tumor). Brit. J. Radiol. 36, 914 (1963).CrossRefGoogle Scholar
  61. Cohen, M. H., J. M. Bennett, C. W. Berard, J. L. Ziegler, C. L. Vogel, J. N. Sheagren, and P. P. Carbone: Burkitt’s tumor in the United States. Cancer (Philad.) 23, 1259 (1969).CrossRefGoogle Scholar
  62. Cohen, M. H., Y. Hirshaut, D. Stevens, E. W. Hull, J. H. Davis, and P. P. Carbone: Infectious mononucleosis followed by Burkitt’s tumor, Ann. intern. Med. 73, 591 (1970).PubMedGoogle Scholar
  63. Cooper, E. H., G. L. Frank, and D. H. Wright: Cell proliferation in Burkitt tumours. Europ. J. Cancer 2, 377 (1966).CrossRefGoogle Scholar
  64. Cooper, E. H., D. T. Hughes, and N. E. Topping: Kinetics and chromosome analyses of tissue culture lines from Burkitt lymphomata. Brit. J. Cancer 20, 102 (1966).PubMedCrossRefGoogle Scholar
  65. Cox, J. N., et S. Widgren: Tumeur de Burkitt: A propos de sept cas au Liberia. J. Suisse Méd. 95, 355 (1965).Google Scholar
  66. Dalldorf, G. F., and F. Bergamini: Unidentified, filterable agents isolated from African children with malignant lymphomas. Proc. nat. Acad. Sci. (Wash.) 51, 263 (1964).CrossRefGoogle Scholar
  67. Dalldorf, G., F. Bergamini, and P. Frost: Further observations of the lymphomas of African children. Proc. nat. Acad. Sci. (Wash.) 55, 297 (1966).CrossRefGoogle Scholar
  68. Dalldorf, G., C. A. Linsell, F. E. Barnhart, and R. Martyn: An epidemiologic approach to the lymphomas of African children and Burkitt’s sarcoma of the jaws. Perspect. Biol. Med. 7, 435 (1964).PubMedGoogle Scholar
  69. Deichmann, G. I.: Immunological aspects of carcinogenesis by deoxyribonucleic acid tumor viruses. Advanc. Cancer Res. 12, 101 (1969).CrossRefGoogle Scholar
  70. Dorfman, R. F.: Childhood lymphoma in St. Louis, Missouri, clinically and histologically resembling Burkitt’s tumour. Cancer (Philad.) 18,418 (1965).CrossRefGoogle Scholar
  71. Douglas, S.D., J. Borjeson, and L. N. Chessin: Studies on human lymphocytes in vitro. IV. Comparative fine structural features of the established Burkitt lymphoma cell lines AL-1, EB-2 and phytomitogen transformed lymphocytes. J. Immunol. 99, 340 (1967).PubMedGoogle Scholar
  72. Edington, G. M., and C. M. U. MacLean: Incidence of the Burkitt tumour in Ibadan, Western Nigeria. Brit. med. J. 1964 I, 264.CrossRefGoogle Scholar
  73. Editorial: Pattern of cancer in Central Africa. Brit. med. J. 1964 I, 321.Google Scholar
  74. Editorial: Burkitt lymphoma and malaria. Lancet 1970 II, 300.Google Scholar
  75. Epstein, M. A.: Long-term tissue culture of Burkitt lymphoma cells. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Linving-stone 1970.Google Scholar
  76. Epstein, M. A.: Aspects of the EB virus. Advanc. Cancer Res. 13, 383 (1970).CrossRefGoogle Scholar
  77. Epstein, M. A., and B. G. Achong: Pine structure organization of human lymphoblasts of a tissue culture strain (EB 1) from Burkitt’s lymphoma. J. nat. Cancer Inst. 34, 241 (1965).PubMedGoogle Scholar
  78. Epstein, M. A., and B. G. Achong: Immunologic relationship of the herpes-like EB-virus of cultured Burkitt-lymphoblasts. Cancer Res. 27, 2489 (1967).PubMedGoogle Scholar
  79. Epstein, M. A., and B. G. Achong: Specific immunofluorescence test for the herpes-type EB virus of Burkitt lymphoblasts, authenticated by electron microscopy. J. nat. Cancer Inst. 40, 593 (1968).PubMedGoogle Scholar
  80. Epstein, M. A., and B. G. Achong: Observations on the nature of the herpes-type EB virus in cultured Burkitt lymphoblasts, using a specific immunofluorescence test. J. nat. Cancer Inst. 40, 609 (1968).PubMedGoogle Scholar
  81. Epstein, M. A., B. G. Achong, and Y. M. Barr: Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964 I, 231.Google Scholar
  82. Epstein, M. A., and Y. M. Barr: Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma. Lancet 1964 I, 252.CrossRefGoogle Scholar
  83. Epstein, M. A., and Y. M. Barr: Characteristics and mode of growth of a tissue culture strain (EB 1) of human lymphoblasts from Burkitt’s lymphoma. J. nat. Cancer Inst. 34, 231 (1965).PubMedGoogle Scholar
  84. Epstein, M. A., Y. M. Barr, and B. G. Achong: Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964 I, 702.CrossRefGoogle Scholar
  85. Epstein, M. A., Y. M. Barr, and B. G. Achong: A second virus-carrying tissue culture strain (EB 2) of lymphoblasts from Burkitt’s lymphoma. Path, et Biol. 12, 1233 (1964).Google Scholar
  86. Epstein, M. A., Y. M. Barr, and B. G. Achong: The behaviour and morphology of a second tissue culture strain (EB 2) of lymphoblasts from Burkitt’s lymphoma. Brit. J. Cancer 19, 108 (1965).PubMedCrossRefGoogle Scholar
  87. Epstein, M. A., Y. M. Barr, and B. G. Achong: Studies with Burkitt-lymphoma. Wistar Inst. Symposium Monograph 4, 69 (1965).Google Scholar
  88. Epstein, M. A., Y. E. Barr, and B. G. Achong: Preliminary observations on new lymphoblastic strains (EB4, EB5) from Burkitt’s tumours in a British and a Ugandan patient. Brit. J. Cancer 20, 475 (1966).PubMedCrossRefGoogle Scholar
  89. Epstein, M. A., G. Henle, B. G. Achong, and Y. M. Barr: Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma. J. exp. Med. 121, 761 (1965).PubMedCrossRefGoogle Scholar
  90. Fahey, J. L., I. Finegold, A. S. Kabson, and R. A. Manaker: Immunoglobulin synthesis in vitro by established human cell lines. Science 152, 1259 (1966).PubMedCrossRefGoogle Scholar
  91. Fass, L., R. Herberman, J. Ziegler, and R. H. Morrow, jr.: Evaluation of the effect of remission plasma on untreated patients with Burkitt’s lymphoma. J. nat Cancer Inst. 44, 145 (1970).PubMedGoogle Scholar
  92. Finegold, I., J. L. Fahey, and H. Granger: Synthesis of immunoglobulins by human cell lines in tissue culture. J. Immunol. 99, 839 (1967).PubMedGoogle Scholar
  93. Floyd, R., V. Vonka, and M. Benyesch-Melnick: Fluorescence complement fixation by lymphoblastoid cells. J. nat. Cancer Inst. 46, 383 (1971).PubMedGoogle Scholar
  94. Frank, G. L.: Involvement of the nervous system in Burkitt’s tumor. In: Clifford, P., A. A. Linsell and G. L. Timms (Eds.): Cancer in Africa. East Africa Publishing House 1968.Google Scholar
  95. Gall, E. A., and H. Rappaport: Seminar on diseases of lymph nodes and spleen. In: Proceedings of the Twenty-third Seminar of the American Society of Clinical Pathologists. Oct. 4, 1957. American Society of Clinical Pathologists 1958.Google Scholar
  96. Gallmeier, W. M., F. W. Goebel, W. Hartung und C. G. Schmidt: Studien an einem Burkitt-Lymphom. Klin. Wschr. 48, 537 (1970).PubMedCrossRefGoogle Scholar
  97. Gerber, P., and M. Birch: Complement-fixing antibodies in sera of human and non-human primates to viral antigens derived from Burkitt’s lymphoma cells. Proc. nat. Acad. Sci. (Wash.) 58, 478 (1967).CrossRefGoogle Scholar
  98. Gerber, P., and J. H. Monroe: Studies on leucocytes growing in continuous culture dervied from normal human donors. J. nat. Cancer Inst. 40, 855 (1968).PubMedGoogle Scholar
  99. Gergely, L., G. Klein, and J. Ernberg: The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines. Int. J. Cancer 7, 293 (1971).PubMedCrossRefGoogle Scholar
  100. Gluckman, J.: Multifocal lymphoma in South Africa. S. Afr. Cancer Bull. 7, 7 (1963).Google Scholar
  101. Goetz, O.: Das Burkitt-Lymphom. Med. Klin. 66, 873 (1971).PubMedGoogle Scholar
  102. Goetz, O., F. Lampert, P. Peller und K. Prechtel: Histologisch und virologisch gesicherter Burkitt-Tumor bei einem 10jährigen Knaben. Münch. med. Wschr. 112, 1373 (1970).PubMedGoogle Scholar
  103. Goldstein, G., G. Klein, G. Pearson, and P. Clifford: Direct membrane immunofluorescence reaction of Burkitt’s lymphoma cells in culture. Cancer Res. 29, 749 (1969).Google Scholar
  104. Griffin, E. R., D. H. Wright, T. M. Bell, and M. G. R. Ross: Demonstration of virus particles in biopsy material from cases of Burkitt-tumor. Europ. J. Cancer 2, 353 (1966).Google Scholar
  105. Gunvén, P., G. Klein, G. Henle, W. Henle, and P. Clifford: Epstein-Barr virus in Burkitt’s lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature (Lond.) 228, 1053 (1970).CrossRefGoogle Scholar
  106. Gutterman, J., V. Rodriguez, and G. McMullan: Remission induction of acute leukemia developing in Burkitt’s lymphoma. Cancer (Philad.) 29, 626 (1972).CrossRefGoogle Scholar
  107. Haddow, A. J.: Age incidence in Burkitt’s lymphoma syndrome. E. Air. med. J. 41, 1 (1964).Google Scholar
  108. Haddow, A. J.: Epidemiological evidence suggesting an infective element in the aetiology. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  109. Harris, R. J. C.: Aetiology of Central African lymphoma. Brit. med. Bull. 20, 149 (1964).PubMedGoogle Scholar
  110. Hellstrom, K. E., and I. Hellström: Cellular immunity against tumor antigens. Adv. Cancer Res. 12, 167 (1969).PubMedCrossRefGoogle Scholar
  111. Henle, G., and W. Henle: Interference in the detection of viral carrier states. Wistar Inst. Symp. Monogr. 4, 83 (1965).PubMedGoogle Scholar
  112. Henle, G., and W. Henle: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bact. 91, 1248 (1966).PubMedGoogle Scholar
  113. Henle, G., and W. Henle: Studies on cell lines derived from Burkitt’s lymphoma. Trans. N. Y. Acad. Sci. 29, 71 (1966).PubMedGoogle Scholar
  114. Henle, G., and W. Henle: Immunofluorescence, interference and complement-fixation technics in the detection of the herpes-type virus in Burkitt tumour cell lines. Cancer Res. 27, 2442 (1967).PubMedGoogle Scholar
  115. Henle, G., W. Henle, P. Clifford, V. Diehl, G. Kafuko, B. G. Kirya, G. Klein, R. H. Morrow, G. R. Munube, P. Pike, P. M. Tukei, and J. L. Ziegler: Antibodies to EB virus in Burkitt’s lymphoma and control groups. J. nat. Cancer Inst. 43, 1147 (1969).PubMedGoogle Scholar
  116. Henle, G., W. Henle, and V. Diehl: Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc. nat. Acad. Sci. 59, 94 (1968).PubMedCrossRefGoogle Scholar
  117. Henle, G., W. Henle, and G. Klein: Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int. J. Cancer 8, 272 (1971).PubMedCrossRefGoogle Scholar
  118. Henle, G., W. Henle, G. Klein, P. Gunvén, P. Clifford, R. H. Morrow, and J. L. Ziegler: Antibodies to early Epstein-Barr virus-induced antigens in Burkitt’s lymphoma. J. nat. Cancer Inst. 46, 861 (1971).PubMedGoogle Scholar
  119. Henle, W., V. Diehl, G. Kohn, H. Zur Hausen, and G. Henle: Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157, 1064 (1967).PubMedCrossRefGoogle Scholar
  120. Henle, W., and G. Henle: Present status of the herpes-group virus associated with cultures of the hematopoietic system. Perspect. Virol. 6, 105 (1968).Google Scholar
  121. Henle, W., G. Henle, H. C. Ho, B. Burtin, Y. Caehin, P. Clifford, A. De Schryver, G. Thé, V. Diehl, and G. Klein: Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J. nat. Cancer Inst. 44, 225 (1970).PubMedGoogle Scholar
  122. Henle, W., G. Henle, G. Pearson, R. Waubke, and M. Scriba: Differential reactivity of human sera with EBV-induced “early antigens”. Science 169, 188 (1970).PubMedCrossRefGoogle Scholar
  123. Henle, W., K. Hummeler, and G. Henle: Antibody coating and agglutination of virus particles separated from the EB 3 line of Burkitt lymphoid cells. J. Bact. 92, 269 (1966).PubMedGoogle Scholar
  124. Herberman, R. B., and J. L. Fahey: Cytotoxic antibody in Burkitt’s tumor and normal human serum reactive with cultures of lymphoid cells. Proc. Soc. exp. Biol. (N.Y.) 127, 938 (1967).Google Scholar
  125. Herlitzka, A. J., M. Badruddoja, and V. E. Dube: Clinical and pathologic features of Burkitt’s lymphoma. Surg. Gynec. Obstet. 136, 81 (1973).PubMedGoogle Scholar
  126. Hinuma, Y., and J. T. Grace: Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long term cultures. Proc. Soc. exp. Biol. (N.Y.) 124, 107 (1967).Google Scholar
  127. Hummeler, K., G. Henle, and W. Henle: Fine structure of a virus in cultured lymphoblasts from Burkitt lymphoma. J. Bact. 91, 1366 (1966).PubMedGoogle Scholar
  128. Irlin, I. S.: Immunofluorescent demonstration of a specific surface antigen in cells infected or transformed by polyoma virus. Virology 32, 725 (1967).PubMedCrossRefGoogle Scholar
  129. Iversen, U., O. H. Iversen, A. Z. Bluming, J. L. Ziegler, and S. Kyalwasi: Cell kinetics of African cases of Burkitt lymphoma. A preliminary report. Eurp. J. Cancer 8, 305 (1972).Google Scholar
  130. Iwakata, S., and J. T. Grace: Cultivation in vitro of myeloblasts from human leukemia. N.Y. St. J. Med. 64, 2279 (1964).Google Scholar
  131. Jacobs, P. A., I. M. Tough, and D. H. Wright: Cytogenetic studies in Burkitt’s lymphoma. Lancet 1963 II, 1144.CrossRefGoogle Scholar
  132. Janota, L.: Involvement of the nervous system in malignant lymphoma in Nigeria. Brit. J. Cancer 20, 47 (1966).PubMedCrossRefGoogle Scholar
  133. Jensen, E. M., W. Korol, S. L. Dittmar, and T. J. Medrek: Virus containing lymphocyte culture fom cancer patients. J. nat. Cancer Inst. 39, 745 (1967).PubMedGoogle Scholar
  134. Jerusalem, C.: Relationship between malaria infection (Plasmodium berghei) and malignant lymphoma in mice. Tropenmed. Parasitol. 19, 94 (1968).Google Scholar
  135. Jerusalem, C.: Lymphatic tissue and germinal centers in immune response. In: Lymphatic tissue and germinal center (Fiore-Donati, M. G. Hanna, Eds.). New York: Plenum Press 1969.Google Scholar
  136. Johansson, B., G. Klein, W. Klein, and G. Henle: Epstein-Barr virus (EBV) associated antibody pattern in malignant lymphoma and leukemia. I. Hodgkin’s disease. Int. J. Cancer 6, 450 (1970).PubMedCrossRefGoogle Scholar
  137. Johansson, B., G. Klein, W. Henle, and G. Henle: Epstein-Barr virus (EBV) associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma. Int. J. Cancer 8, 475 (1971).PubMedGoogle Scholar
  138. Kamei, H., and G. E. Moore: Production of phageneutralizing activity in vitro by cells derived from Burkitt’s lymphoma. Nature (Lond.) 215, 860 (1967).CrossRefGoogle Scholar
  139. Kamei, H., and G. E. Moore: Antibody production stimulated in vitro in Burkitt lymphoma cells. J. Immunol. 101, 587 (1968).PubMedGoogle Scholar
  140. Kaplan, H.: On the natural history of the Murine leukemias: Presidential address. Cancer Res. 27, 1325 (1967).PubMedGoogle Scholar
  141. Karp, L. A., L. E. Zimmerman and T. Payne: Intraocular involvement in Burkitt’s lymphoma. Arch. Ophthal. 85, 295 (1971).PubMedGoogle Scholar
  142. Khan, A. G.: The multifocal lymphoma syndrome in African children in Kenya. J. Laryng. 78, 480 (1964).PubMedCrossRefGoogle Scholar
  143. Klein, E. and G. Klein: Antigenic properties of lymphomas induced by the Moloney agent. J. nat. Cancer Inst. 32, 547 (1964).PubMedGoogle Scholar
  144. Klein, G.: Tumor antigens. Ann. Rev. Microbiol. 20, 223(1966).CrossRefGoogle Scholar
  145. Klein, G.: Specificity of cell surface. New Yersey: Prentice Hall 1967.Google Scholar
  146. Klein, G.: Tumor-specific transplantation antigens. C.H.A. Clowes memorial lecture. Cancer Res. 28, 625 (1968).PubMedGoogle Scholar
  147. Klein, G.: Some immunological studies. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  148. Klein, G.: Immunological studies on Burkitt’s lymphoma. Postgrad, med. J. 47, 141 (1971).CrossRefGoogle Scholar
  149. Klein, G., P. Clifford, E. Klein, R. T. Smith, J. Minowada, F. M. Kourilsky and J. H. Burehenal: Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimen and tissue cultures. J. nat. Cancer Inst. 39, 1027 (1967).PubMedGoogle Scholar
  150. Klein, G., P. Clifford, E. Klein, and Barnes, D. K., Cleveland, R. W. (1963): Crop. Sci. 3, 295 (79).: Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reation. Proc. nat. Acad. Sci. (Wash.) 55, 1628 (1966).CrossRefGoogle Scholar
  151. Klein, G., P. Clifford, E. Klein, and J. Stjernswärd: Search for tumour specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. In: Burehenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  152. Klein, G., E. Klein, and P. Clifford: Search for host defences in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Res. 27, 2510 (1967).PubMedGoogle Scholar
  153. Klein, G., G. Pearson, G. Goldstein, W. Henle, G. Henle, and P. Clifford: Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. III. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J. exp. Med. 129, 697 (1969).PubMedCrossRefGoogle Scholar
  154. Klein, G., G. Pearson, G. Henle, W. Henle, V. Diehl, and J. C. Niederman: Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt’s tumour cells. II. Comparison of cells and sera from patients with Burkitt’s lymphoma and infectious mononucleosis. J. exp. Med. 128, 1021 (1968).PubMedCrossRefGoogle Scholar
  155. Klein, G., G. Pearson, J. S. Nadkarni, J. J. Nadkarni, E. Klein, G. Henle, W. Henle, and P. Clifford: Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence of EB virus. J. exp. Med. 128, 1011 (1968).PubMedCrossRefGoogle Scholar
  156. Kohn, G., V. Diehl, W. J. Mellman, W. Henle, and G. Henle: C-group chromosome marker in long-term leukocytes cultures. J. nat. Cancer Inst. 41, 795 (1968).PubMedGoogle Scholar
  157. Kohn, G., W. J. Mellman, P. S. Moorhead, J. Loftus, and G. Henle: Involvement of C group chromosomes in five Burkitt lymphoma cell lines. J. nat. Cancer Inst. 38, 209 (1967).PubMedGoogle Scholar
  158. Kurita, Y., T. Osato, and Y. Jto: Studies on chromosomes of three human cell lines hartoring the EB virus particles. J. nat. Cancer Inst. 41, 1355 (1688).Google Scholar
  159. Kurnick, N. B.: Pyronin Y in the methylgreen-pyronin histological stain. Stain Technol. 30, 213 (1955).PubMedGoogle Scholar
  160. Lambert, D.: Les haematosarcomes de la face chez l’enfant en Afrique (maladie de Burkitt). Thèse pour le Doctorat en Medicine, Faculté de Médecine de Paris 1965.Google Scholar
  161. Levine, P. H., G. T. O’Conor, and C.W. Bernard: Antibodies to Epstein-Barr virus (EBV) in american patients with Burkitt’s lymphoma. Cancer (Philad.) 30, 610 (1972).CrossRefGoogle Scholar
  162. Levine, P. H., S. G. Sandler, D. M. Komp, G. T. O’Conor, and M. O’Connor: Simultaneous occurrence of “American Burkitt’s lymphoma” in neighbors. New Engl. J. Med. 288, 562 (1973).PubMedCrossRefGoogle Scholar
  163. Lherisson, A. M., G. Meyer, and H. Bonneau: Détection d’un antigène de membrane dans le système tumoral polyome-hamster. Bull. Cancer 54, 419 (1967).PubMedGoogle Scholar
  164. Luisi, A., A. P. de Bertelli, J.C. Machado, y J.P. Ache de Freitas: „Linfoma Africano“em criancas Brasileiras. Rev. bras. Cirurg. 49, 280 (1965)Google Scholar
  165. Luisi, A., A. P. de Bertelli, J.C. Machado, y J.P. Ache de Freitas: „Linfoma Africano“em criancas Brasileiras. Bol. Oncol. 49, 280 (1965).Google Scholar
  166. Macek, M., E. H. Seidel, R. T. Lewis, J. P. Brunschwig, J. Wimberly, and M. Benyesh-Melnick: Cytogenetic studies of EB virus-positive and EB virus-negative lymphoblastoid cell lines. Cancer Res. 31, 308 (1971).PubMedGoogle Scholar
  167. Mayyasi, S. A., G. Schidlovsky, L. M. Bulfone, and F. T. Busehesk: The coating reaction of the herpes-type virus isolated from malignant tissues with an antibody present in sera. Cancer Res. 27, 2020 (1967).PubMedGoogle Scholar
  168. McClatchie, S.: Histology of Burkitt’s lymphoma. Brit. Med. J. 1971 I, 669.CrossRefGoogle Scholar
  169. McFarlane, H., R. O. Barrow, V. A. Ngu, and O. Osunkoya: Excretion of immunoglobulins in Burkitt’s lymphoma. Brit. J. Cancer 24, 258 (1970).PubMedCrossRefGoogle Scholar
  170. Meyer-Burg, J.: Burkitt-Tumor. Med. Klin. 65, 865 (1970).PubMedGoogle Scholar
  171. Meyer-Burg, J., und J. Ruckes: Beiderseitige Ovarialsarkome einer zwanzigjährigen Frau, klinisch wie ein Burkitt-Tumor verlaufend. Med. Klin. 67, 86 (1972).PubMedGoogle Scholar
  172. Michalany, J., and Brewbaker, J. (1957): J. Heredity 48, 271 (10, 11).: Primary reticulosarcoma (malignant lymphoma) of the jaw. An. Sta Casa Santos 2, 43 (1962).Google Scholar
  173. Miles, C. P., and F. O’Neill: Chromosome studies in 8 in vitro lines of Burkitt’s lymphoma. Cancer Res. 27, 392 (1967).PubMedGoogle Scholar
  174. Minowada, J., G. Klein, P. Clifford, E. Klein, and G. E. Moore: Studies on Burkitt lymphoma cells. I. Establishment of a cell line (B 35 M) and its characteristics. Cancer (Philad.) 20, 1430 (1967).CrossRefGoogle Scholar
  175. Möller, G.: Demonstration of mouse isoantigens at the cellular level by the fluorescent antibody technique. J. exp. Med. 114, 415 (1961).PubMedCrossRefGoogle Scholar
  176. Moore, G. E., R. E. Gerner, and H. A. Franlin: Culture of normal human leucocytes. J. Amer. med. Ass. 199, 519 (1967).CrossRefGoogle Scholar
  177. Moore, G. E., J. T. Grace, P. Citron, R. Gerner, and A. Burns: Leukocytes cultures of patients with leukemia and lymphomas. N. Y. St. J. Med. 66, 2757 (1966).Google Scholar
  178. Morrow, R. H., M. C. Pike, and A. Kisuule: Survival of Burkitt’s lymphoma patients in Mulago Hospital, Uganda. Brit. med. J. 1967 I, 323.CrossRefGoogle Scholar
  179. Morrow, R.H., M. C. Pike, P. G. Smith, J. L. Ziegler, and A. Kisuule: Burkitt’s lymphoma: a time-space cluster of cases in Bwamba Country of Uganda. Brit. med. J. 1971 II, 491.CrossRefGoogle Scholar
  180. Morton, D. L., R. A. Malmgren, E. C. Holmes, and A. S. Ketcham: Demonstration of antibodies against human malignant melanoma by immunfluorescence. Surgery 64, 233 (1968).PubMedGoogle Scholar
  181. Moses, A. L., P. R. Glade, J. A. Kasel, A. L. Rosenthal, Y. Hirshaut, and L. N. Chessin: Infectious mononucleosis: Detection of herpes like virus and aggregates of small cytoplasmic particles in continuous lymphoid cell lines derived from peripheral blood. Proc. nat. Acad. Sci. (Wash.) 60, 489 (1968).CrossRefGoogle Scholar
  182. Nadkarni, J. S., J. J. Nadkarni, P. Clifford, G. Manolov, E. M. Fenyö, and E. Klein: Characteristics of new cell lines derived from Burkitt lymphomas. Cancer (Philad.) 23, 64 (1969).CrossRefGoogle Scholar
  183. Ngu, V. A.: The African lymphoma (Burkitt tumour) survivals exceeding two years. Brit. J. Cancer 19, 101 (1965).CrossRefGoogle Scholar
  184. Ngu, V. A.: Host defences to Burkitt tumour. Brit. med. J. 1967 I, 345.Google Scholar
  185. Ngu, V. A.: Clinical experience in the therapy of Burkitt tumour. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  186. Ngu, V. A.: Chemotherapy of Burkitt’s tumor at the University of Ibadan, Nigeria. J. Amer. med. Ass. 222, 1166 (1972).CrossRefGoogle Scholar
  187. Ngu, V. A., D. P. Burkitt, and B. O. Osunkoya: Clinical and related evidence of host defence mechanisms. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  188. Niederman, J. C., R. W. McCollum, G. Henle, and W. Henle: Infectious mononucleosis. Clinical manifestations in relation to EB-virus antibodies. J. Amer. med. Ass. 203, 205 (1968).CrossRefGoogle Scholar
  189. O’Conor, G. T.: Malignant lymphoma in African children. A pathological entity. Cancer (Philad.) 14, 270 (1961).CrossRefGoogle Scholar
  190. O’Conor, G. T.: Significant aspects of childhood lymphoma in Africa. Cancer Res. 23, 1514 (1963).PubMedGoogle Scholar
  191. O’Conor, G. T., and J. N. P. Davies: Malignant tumors in African children. J. Pediat. 56, 526 (1960).PubMedCrossRefGoogle Scholar
  192. O’Conor, G. T., and A. S. Rabson: Herpeslike particles in an American lymphoma: Preliminary note. J. nat. Cancer Inst. 35, 899 (1965).Google Scholar
  193. O’Conor, G. T., H. Rappaport, and E. B. Smith: Childhood lymphoma resembling Burkitt’s tumor in the M.S. Cancer (Philad.) 18, 411 (1965).CrossRefGoogle Scholar
  194. Odeku, E. L., and B. O. Osuntokun: The clinical neurology of Burkitt’s neoplasm. A preliminary evaluation based on 105 cases. W. Afr. med. J. 27, 263 (1968).Google Scholar
  195. Clausen, K.E. (1962): Pollen et Spores 4,168 (28)., and L. J. Old: Definition of an antigenic system associated with Burkitt-lymphoma. Cancer Res. 27, 2532 (1967).PubMedGoogle Scholar
  196. Oettgen, H. F., L. J. Old, and E. A. Boyse: Human tumor immunology. Med. Clin. N. Amer. 55, 761 (1971).PubMedGoogle Scholar
  197. Old, L. J., and E. A. Boyse: Immunology of experimental tumors. Ann. Rev. Med. 15, 167 (1964).PubMedCrossRefGoogle Scholar
  198. Old, L. J., E. A. Boyse, G. Geering, and H. F. Oettgen: Serological approaches to the study of cancer in animals and in man. Cancer Res. 28, 1288 (1968).PubMedGoogle Scholar
  199. Old, L. J., J. Kirkwood, H. F. Oettgen, E. de Harven, B. Williamson, and P. Clifford: Precipitating antibody in human serum to an antigen present in cultured Burkitt-lymphoma cells. Proc. nat. Acad. Sci. (Wash.) 56, 1699 (1956).CrossRefGoogle Scholar
  200. Osunkoya, B. O.: Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals. Brit. J. Cancer 21, 302 (1967).PubMedCrossRefGoogle Scholar
  201. Osunkoya, B. O.: Various aspects of the Burkitt tumour cell in tissue culture with reference to host defences. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  202. Osunkoya, B. O.: Short-term tissue culture. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  203. Osunkoya, B. O., and Daniel, L. (1955): Novenytermeles 4,315 (57).: Formal discussion: Observation on the establishment of Burkitt’s tumor lymphoblasts in serially propagated cultures. Cancer Res. 27, 2500 (1967).PubMedGoogle Scholar
  204. Pasternak, G.: Antigen induced by the mouse leukemia viruses. Adv. Cancer Res. 12, 1 (1969).PubMedCrossRefGoogle Scholar
  205. Pike, M. C., E. H. Williams, and B. Wright: Burkitt’s tumour in the West Nile District of Uganda 1961–1965. Brit. med. J. 1967 II, 395.Google Scholar
  206. Pope, J. H.: Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus. Australien J. exp. Biol, med. Sci. 46, 643 (1968).CrossRefGoogle Scholar
  207. Pope, J. H., B. G. Achong, and M. A. Epstein: Cultivation and fine structure of virus bearing lymphoblast from a second New Guinea Burkitt lymphoma: establishment of sublines with unusual cultural properties. Int. J. Cancer 3, 171 (1968).PubMedCrossRefGoogle Scholar
  208. Pope, J. H., B. G. Achong, M. A. Epstein, and J. Biddulph: Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure. J. nat. Cancer Inst. 39, 933 (1967).PubMedGoogle Scholar
  209. Pulvertaft, R. J. V.: Cytology of Burkitt’s tumour (African lymphoma). Lancet 1964 I, 238.Google Scholar
  210. Rabson, A. S., G. T. O’Connor, S. Baron, J. J. Whang, and F. Y. Legallais: Morphologie, cytogenetic and virologic studies in vitro of an malignant lymphoma from an African child. Int. J. Cancer 1, 89 (1966).PubMedCrossRefGoogle Scholar
  211. Schmaman, A.: The Burkitt lymphoma syndrome in Johannesburg. S. Afr. med. J. 39, 741 (1965).PubMedGoogle Scholar
  212. Schryver, A. De, G. Klein, and G. De Thé: Surface antigens on lymphoblastoid cells derived from nasopharyngeal carcinoma. Clin. exp. Immunol. 7, 161 (1970).PubMedGoogle Scholar
  213. Shepherd, J., and D. H. Wright: Brit. J. Surg. 54, 776 (1967).PubMedCrossRefGoogle Scholar
  214. Sjögren, H. O.: Transplantations methods as a tool for detection of tumor specific antigens. Progr. exp. Tumor Res. (Basel) 6, 289 (1965).Google Scholar
  215. Stevens, D. A., G. T. O’Conor, P. H. Levine, and R. B. Rosen: Acute leukemia with “Burkitt’s lymphoma cells” and Burkitt’s lymphoma. Simultaneous onset in american siblings; description of a new entity. Ann. intern. Med. 76, 967 (1972).PubMedGoogle Scholar
  216. Stewart, S. E., E. Lovelace, J. J. Whang, and V. A. Ngu: Burkitt tumour; tissue culture, cytogenetic and virus studies. J. nat. Cancer Inst. 34, 319 (1965).PubMedGoogle Scholar
  217. Stjernswärd, J., P. Clifford, and E. Svedmyr: General tumour-distinctive cellular immunological reactivity. In: Burkitt, D. P., and D. H. W. Right (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  218. Sutton, R. N. P., S. D. Marston, and R. T. D. Emond: Some observations on complement fixing antibodies to the EB virus. J. clin. Path. 24, 801 (1971).PubMedCrossRefGoogle Scholar
  219. Tanigaki, N., Y. Yagi, G. E. Moore, and D. Pressman: Immunoglobulin production in human leukaemia cell lines. J. Immunol. 97, 634 (1966).PubMedGoogle Scholar
  220. Ten Seldam, R. E. J., R. Cooke, and L. Atkinson: Childhood lymphoma in the territories of Papua and New Guinea. Cancer (Philad.) 19, 437 (1966).CrossRefGoogle Scholar
  221. Tevethia, S. S., L. A. Couvillion, and F. Rapp: Development in hamsters of antibodies against surface antigen present in cell transformed by papova virus SV 40. J. Immunol. 100, 358 (1968).PubMedGoogle Scholar
  222. Tomkins, G. A.: Chromosome studies on cultured lymphoblast cell lines from cases of New Guinea Burkitt lymphoma, myeloblastic and lymphoblastic leukemia and infectious mononucleosis. Int. J. Cancer 3, 644 (1968).PubMedCrossRefGoogle Scholar
  223. Toshima, S., N. Takagi, J. Minowada, G. E. Moore, and A. A. Sandberg: Electron microscopic and cytogenetic studies of cells derived from Burkitt’s lymphoma. Cancer Res. 27, 753 (1967).PubMedGoogle Scholar
  224. Tough, I. M., D. G. Harnden, and M. A. Epstein: Chromosome markers in cultured cells from Burkitt’s lymphoma. Europ. J. Cancer 4, 637 (1968).CrossRefGoogle Scholar
  225. Wakefield, J. D., G. J. Thorbeeke, L. J. Old, and E. A. Boyse: Production of immunoglobulins and their subunits by human tissue culture cell lines. J. Immunol. 99, 308 (1967).PubMedGoogle Scholar
  226. Wakelin, P. O.: Malignant lymphoma. Annual Report of Nixon Memorial Hospital 1962–1963 (1964).Google Scholar
  227. Waubke, R.: Epstein-Barr-Virus, infektiöse Mononukleose und Burkitt-Lymphom. Dtsch. med. Wschr. 95, 1572 (1970).PubMedCrossRefGoogle Scholar
  228. Wedderburn, N.: Effect of concurrent malarial infection on development of virus induced lymphoma in Balb/C mice. Lancet 1970 II, 1114.CrossRefGoogle Scholar
  229. Wilkinson, H. A. III, G. M. Hutchins, and W. H. Hartmann: Occurrence of “African lymphoma syndrome” in Baltimore, Maryland. Johns Hopk. med. J. 121, 21 (1967).Google Scholar
  230. Williams, M. C.: Implications of the geographical distribution of Burkitt’s lymphoma. In: Burchenal, J. H., and D. P. Burkitt (Eds.): Treatment of Burkitt’s tumour. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  231. Williams, E. H.: A comparison of results achieved in treating two series of patients with Burkitt’s lymphoma. Brit. J. Cancer 25, 37 (1971).PubMedCrossRefGoogle Scholar
  232. Wosornu, J. L., F. K. Nkrumah, and I. V. Perkins: Survial of Burkitt’s lymphoma patients in Ghana. Brit. J. Cancer 25, 479 (1971).PubMedCrossRefGoogle Scholar
  233. Wright, D. H.: Burkitt’s tumour. A postmortem study of 50 cases. Brit. J. Surg. 51, 245 (1964).PubMedCrossRefGoogle Scholar
  234. Wright, D. H.: Cytology and histochemistry of the malignant lymphomas seen in Uganda. The lymphoreticular tumours in Africa. U.I.C.C. Symposium, Paris 1963. Basel-New York: Karger 1964.Google Scholar
  235. Wright, D. H.: Lymphoma in Africa. Israel J. med. Sci. 1, 177 (1965).PubMedGoogle Scholar
  236. Wright, D. H.: Burkitt’s tumor in England, a comparison with childhood lymphosarcoma. Int. J. Cancer 1, 503 (1966).PubMedCrossRefGoogle Scholar
  237. Wright, D. H.: The epidemiology of Burkitt’s tumor. Cancer Res. 27, 2424 (1967).PubMedGoogle Scholar
  238. Wright, D. H.: Microscopic features, histochemistry, histogenesis and diagnosis. In: Burkitt, D. P., and D. H. Wright (Eds.): Burkitt’s lymphoma. Edinburgh and London: E. & S. Livingstone 1970.Google Scholar
  239. Wright, D. H.: Reed-Sternberg-like cells in recurrent Burkitt lymphomas. Lancet 1970 I, 1052.CrossRefGoogle Scholar
  240. Wright, D. H.: Burkitt’s lymphoma and malaria. Lancet 1970 II, 881.CrossRefGoogle Scholar
  241. Wright, D. H., and P. A. Pike: Bone marrow involvement in Burkitt’s tumour. Brit. J. Haemat. 15, 409 (1968).PubMedCrossRefGoogle Scholar
  242. Zeve, V. H., L. S. Lucas, and R. A. Manaker: Continuous cell culture from a patient with chronic myelogenous leukemia. II. Detection of a herpes-like virus by electron microscopy. J. nat. Cancer Inst. 37, 761 (1966).PubMedGoogle Scholar
  243. Ziegler, J. L.: Chemotherapy of Burkitt’s lymphoma. Cancer (Philad.) 30, 1534 (1972).CrossRefGoogle Scholar
  244. Ziegler, J. L.: Das Burkitt-Lymphom. Münch. med. Wschr. 114, 13 (1972).PubMedGoogle Scholar
  245. Ziegler, J. L., and A. Z. Bluming: Intrathecal chemotherapy in Burkitt’s lymphoma. Brit. med. J. 1971 III, 508.CrossRefGoogle Scholar
  246. Ziegler, J. L., A. Z. Bluming, L. Fass, and R. H. Morrow, Jr.: Relapse patterns in Burkitt’s lymphoma. Cancer Res. 32, 1267 (1972).PubMedGoogle Scholar
  247. Ziegler, J. L., A. Z. Bluming, R. H. Morrow, Jr., M. H. Cohen, E. H. Fife, Jr., J. F. Finerty, and R. Woods: Burkitt’s lymphoma and malaria. Trans. roy. Soc. trop. Med. Hyg. 66, 285 (1972).PubMedCrossRefGoogle Scholar
  248. Ziegler, J. L., A. Z. Bluming, R. H. Morrow, L. Fass, and P. P. Carbone: Central nervous system involvement in Burkitt’s lymphoma. Blood 36, 718 (1970).PubMedGoogle Scholar
  249. Ziegler, J. L., A. Z. Bluming, and A. C. Templeton: Burkitt’s lymphoma and tropical splenomegaly syndrome. Lancet 1971 II, 317.CrossRefGoogle Scholar
  250. Ziegler, J. L., M. H. Cohen, R. H. Morrow, S. K. Kyalwazi, and P. P. Carbone: Immunologic studies in Burkitt’s lymphoma. Cancer (Philad.) 25, 734 (1970).CrossRefGoogle Scholar
  251. Ziegler, J. L., and L.-B. Goodman: Kinetic studies of established cell lines of Burkitt’s lymphoma. In press.Google Scholar
  252. Ziegler, J. L., R. H. Morrow, Jr., L. Fass, S. K. Kyalwazi, and P. P. Carbone: Treatment of Burkitt’s tumor with cyclophosphamide. Cancer (Philad.) 26, 474 (1970).CrossRefGoogle Scholar
  253. Ziegler, J. L., R. H. Morrow, Jr., A. C. Templeton, C. Templeton, A. Z. Bluming, L. Fass, and S. K. Kyalwazi: Clinical features and treatment of childhood malignant lymphoma in Uganda. Int. J. Cancer 5, 415 (1970).PubMedCrossRefGoogle Scholar
  254. Ziegler, J. L., D. H. Wright, and S. K. Kyalwazi: Differential diagnosis of Burkitt’s lymphoma of the face and jaws. Cancer (Philad.) 27, 503 (1971).CrossRefGoogle Scholar
  255. Zur Hausen, H., W. Henle, H. Kummeler, V. Diehl, and G. Henle: Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography and electron microscopy. J. Virol. 1, 830 (1967).PubMedGoogle Scholar
  256. Zur Hausen, H., and H. Sehulte-Holthausen: Presence of EB virus nucleic acid homology in a “Virus-free” line of Burkitt tumour cells. Nature (Lond.) 227, 245 (1970).CrossRefGoogle Scholar
  257. Zur Hausen, H., H. Sehulte-Holthausen, G. Klein, W. Henle, G. Henle, P. Clifford, and L. Santesson: EB-virus DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (Lond.) 228, 1016 (1970).CrossRefGoogle Scholar
  258. Zur Hausen, H., H. Sehulte-Holthausen, G. Klein, W. Henle, G. Henle, P. Clifford, and L. Santesson: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (Lond.) 228, 1056 (1970).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1974

Authors and Affiliations

  • Johann Rastetter

There are no affiliations available

Personalised recommendations